Thompson Group

Discovery and development of small molecule and peptide therapeutics

We apply a chemistry-centred approach to a broad array of drug target classes (kinase inhibitors, protease inhibitors, peptide GPCRs, epigenetic targets, PROTACs) and therapeutic areas (infectious diseases, oncology, diabetes and fibrotic disorders).